Taiwan FDA registration a695a94b13ffc08f2f591a1a78932be6

Imno Consester Antineutrophil Cytoplasmic Autologous Antibody Assay System

TW: 伊姆諾康塞斯特抗嗜中性球細胞質自體抗體測定系統

Taiwan·Risk Class 2·IMMUNO CONCEPTS NA LTD·Registered Mar 21, 2006 – Mar 21, 2016Cancelled

Registration details

Analysis ID: a695a94b13ffc08f2f591a1a78932be6
Customs Code: DHA00601618304

Company information

Manufacturer: IMMUNO CONCEPTS NA LTD
Manufacturer Country: United States
Authorized Representative: GRANT TECHNOLOGY CO., LTD.

Product details

Intended Use: Semi-quantitative determination of anti-neutrophil cytoplasmic autologous antibodies in human serum by indirect fluorescent antibody assay.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5660 多發性自體抗體免疫試驗系統
Import Information: import

Dates and status

Registration Date: Mar 21, 2006
Expiry Date: Mar 21, 2016
Cancellation Date: May 10, 2018

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for Imno Consester Antineutrophil Cytoplasmic Autologous Antibody Assay System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a695a94b13ffc08f2f591a1a78932be6 and manufactured by IMMUNO CONCEPTS NA LTD. The authorized representative in Taiwan is GRANT TECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.